Pulsed [phpr]
estrogen therapy [topp]
haemostatic [ortf]
Marker [clna]
Comparison [acty]
Oral [spco]
Estrogen [horm, phsu, strd]
Regimen [topp]
postmenopausal [tmco]
Women [popg]
Aims [idcn]
Hormone replacement therapy [topp]
Increased [qnco]
Thromboembolism [dsyn]
Dependent [qlco]
Hormone replacement therapy [topp]
Compared [acty]
Therapy Effect [fndg]
Intranasal [spco]
Oral [spco]
Estrogens [horm, phsu, strd]
Coagulation [ortf]
Fibrinolysis [phsf]
Marker [clna]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
randomized [resa]
Study [mnob]
Health [idcn]
Women [popg]
Received [qlco]
Intranasal [spco]
17 beta-Estradiol [horm, phsu, strd]
Oral [spco]
Estrogens [horm, phsu, strd]
3 Months [tmco]
baseline [bodm]
Characteristics [qlco]
Group [idcn]
Women [popg]
Receive [qlco]
Intranasal [spco]
Estradiol [horm, phsu, strd]
Mild [qlco]
Increment [qnco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
P NOS [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
Factor VII [aapp, bacs, phsu]
Tissue Factor [aapp, imft]
Complex [qlco]
Antithrombin III [aapp, phsu]
protein activity [moft]
Copyright [inpr]
protein activity [moft]
Plasminogen [aapp, bacs, phsu]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
Antigen [imft]
Unchanged [fndg]
Contrast [qlco]
Oral [spco]
Estrogens [horm, phsu, strd]
Elevated [qlco]
type antigen [inpr]
Plasminogen Activator [aapp, enzy, phsu]
P NOS [aapp, imft]
In [qnco]
Parallel [qlco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
P NOS [aapp, imft]
mU/mL [qnco]
P NOS [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Protein C [aapp, bacs, phsu]
Protein S [aapp, bacs]
Plasminogen [aapp, bacs, phsu]
Unchanged [fndg]
Conclusions [idcn]
Nasal [bpoc]
17 beta-Estradiol [horm, phsu, strd]
Coagulation [ortf]
Marker [clna]
Moderate [qlco]
Increment [qnco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Contrast [qlco]
Oral [spco]
Estrogens [horm, phsu, strd]
elicited [qlco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Normal limits [qnco]
Copyright [inpr]
basel [hcro]
